HK1105202A1 - Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient - Google Patents

Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient

Info

Publication number
HK1105202A1
HK1105202A1 HK07110520.1A HK07110520A HK1105202A1 HK 1105202 A1 HK1105202 A1 HK 1105202A1 HK 07110520 A HK07110520 A HK 07110520A HK 1105202 A1 HK1105202 A1 HK 1105202A1
Authority
HK
Hong Kong
Prior art keywords
malignant
active ingredient
same
agent containing
heterocyclic compound
Prior art date
Application number
HK07110520.1A
Other languages
English (en)
Inventor
Seiichiro Kawashima
Toshiyuki Matsuno
Shinichi Yaguchi
Yoshio Tsuchida
Kenichi Saitoh
Tetsuo Watanabe
Original Assignee
Zenyaku Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zenyaku Kogyo Kk filed Critical Zenyaku Kogyo Kk
Publication of HK1105202A1 publication Critical patent/HK1105202A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
HK07110520.1A 2004-03-31 2007-09-27 Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient HK1105202A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004103273 2004-03-31
PCT/JP2005/006111 WO2005095389A1 (ja) 2004-03-31 2005-03-30 複素環式化合物及びそれを有効成分とする抗悪性腫瘍剤

Publications (1)

Publication Number Publication Date
HK1105202A1 true HK1105202A1 (en) 2008-02-06

Family

ID=35063701

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07110520.1A HK1105202A1 (en) 2004-03-31 2007-09-27 Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient

Country Status (11)

Country Link
US (1) US7855199B2 (xx)
EP (1) EP1741714B1 (xx)
JP (1) JP4733021B2 (xx)
KR (1) KR101130913B1 (xx)
CN (1) CN100532380C (xx)
AU (1) AU2005227954B2 (xx)
CA (1) CA2561406C (xx)
DK (1) DK1741714T3 (xx)
ES (1) ES2400056T3 (xx)
HK (1) HK1105202A1 (xx)
WO (1) WO2005095389A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002253619B2 (en) 2001-04-27 2007-05-17 Zenyaku Kogyo Kabushiki Kaisha Heterocyclic compound and antitumor agent containing the same active ingredients
RU2443441C2 (ru) 2005-03-11 2012-02-27 Зеняку Когио Кабусикикайся Иммунодепрессант и противоопухолевое средство, содержащее гетероциклическое соединение в качестве активного ингредиента
WO2008032077A1 (en) * 2006-09-14 2008-03-20 Astrazeneca Ab Pyrimidine derivatives
JP5479912B2 (ja) 2007-11-22 2014-04-23 全薬工業株式会社 複素環式化合物の非晶質体、それを含む固体分散体、薬剤、およびその製造法
EP2276750A2 (en) * 2008-03-27 2011-01-26 Auckland Uniservices Limited Substituted pyrimidines and triazines and their use in cancer therapy
CN102317282A (zh) 2009-02-12 2012-01-11 安斯泰来制药有限公司 杂环衍生物
CN102448958B (zh) 2009-03-27 2015-10-21 维特Dc公司 嘧啶基和1,3,5-三嗪基苯并咪唑磺酰胺和其在癌症治疗中的用途
CA2987503C (en) 2009-07-07 2019-02-26 Mei Pharma, Inc. Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
JP5765342B2 (ja) * 2010-08-10 2015-08-19 アステラス製薬株式会社 へテロ環化合物
WO2012044641A1 (en) * 2010-09-29 2012-04-05 Pathway Therapeutics Inc. 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
BR112013024907A2 (pt) 2011-03-28 2016-12-20 Mei Pharma Inc composto, composição farmacêutica, método para o tratamento, prevenção ou atenuação de um ou mais sintomas de um distúrbio, doença ou condição mediada por pi3k em um sujeito, método para modular a atividade enzimática de pi3k
CN105175410B (zh) * 2015-10-14 2018-01-05 湖南华腾制药有限公司 三嗪类化合物及其制备方法和抗肿瘤应用
KR20200009088A (ko) 2017-05-23 2020-01-29 메이 파마, 아이엔씨. 병용 요법
US11351176B2 (en) 2017-08-14 2022-06-07 Mei Pharma, Inc. Combination therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW312694B (xx) * 1994-09-26 1997-08-11 Daiichi Seiyaku Co
US6251900B1 (en) 1997-07-24 2001-06-26 Zenyaku Kogyo Kabushiki Kaisha Heterocyclic compounds and antitumor agent containing the same as active ingredient
AU2002253619B2 (en) 2001-04-27 2007-05-17 Zenyaku Kogyo Kabushiki Kaisha Heterocyclic compound and antitumor agent containing the same active ingredients
WO2004032930A1 (ja) * 2002-10-11 2004-04-22 Kowa Co., Ltd. 癌の処置方法
ES2389253T3 (es) 2002-10-25 2012-10-24 Zenyaku Kogyo Kabushiki Kaisha Compuestos heterocíclicos y agentes antitumorales que comprenden los mismos como ingrediente activo

Also Published As

Publication number Publication date
EP1741714B1 (en) 2013-01-09
JP4733021B2 (ja) 2011-07-27
KR20070008670A (ko) 2007-01-17
CA2561406A1 (en) 2005-10-13
EP1741714A4 (en) 2007-09-12
US20080287431A1 (en) 2008-11-20
ES2400056T3 (es) 2013-04-05
CN100532380C (zh) 2009-08-26
WO2005095389A1 (ja) 2005-10-13
CA2561406C (en) 2012-07-03
US7855199B2 (en) 2010-12-21
JPWO2005095389A1 (ja) 2008-02-21
AU2005227954A1 (en) 2005-10-13
DK1741714T3 (da) 2013-04-15
AU2005227954B2 (en) 2011-02-10
KR101130913B1 (ko) 2012-03-28
CN1972935A (zh) 2007-05-30
EP1741714A1 (en) 2007-01-10

Similar Documents

Publication Publication Date Title
HK1105202A1 (en) Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient
HK1118016A1 (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
IL170690A0 (en) Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
IL181783A0 (en) Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
EP1932833A4 (en) NITROGENATED HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
IL178297A0 (en) Hydrazide derivatives and pharmaceutical compositions containing the same
IL179837A0 (en) Cyclic and heterocyclic compounds having anti-bacterial activity and pharmaceutical compositions containing the same
IL174128A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL191141A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL186665A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL187434A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
ZA200702684B (en) 3-triazolylphenyl sulfide derivative and insecticide/ acaricide/nematicide containing the same as active ingredient
PL372084A1 (en) 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
EP1970377A4 (en) LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THIS AS AN ACTIVE SUBSTANCE
HK1086830A1 (en) Heterocyclic compounds and antitumor drugs containing the same as the active ingredient
EP1780202A4 (en) QUINOLINE DERIVATIVE AND INSECTICIDE CONTAINING CELLUI-CI AS ACTIVE INGREDIENT
IL192184A0 (en) Heterocyclic derivatives and pharmaceutical compositions containing the same
PT1937664E (pt) Composto de hidrazida e utilização pesticida do mesmo
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
IL192298A (en) Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them
IL175359A0 (en) Herbicidally active agent
IL190506A0 (en) Amide derivatives and pesticidal compositions containing the same
IL182664A0 (en) Triazole derivatives and pharmaceutical compositions containing the same
IL174249A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL164699A0 (en) Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170330